Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review.

Scandinavian Journal of Urology
Peter J BoströmKari T Syvänen

Abstract

Context: Radical cystectomy and pelvic lymph node dissection (RC and PLND) are an essential part of the treatment paradigm in high risk bladder cancer. However, these patients have high rates of morbidity and mortality related both to the treatment and to the disease.Objective: To provide overview of current literature about clinical markers that can be used to predict and improve BC-patient outcomes at the time of RC and PLND and to study if they are properly validated.Evidence acquisition: A systematic literature search was conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria between January 1990 and October 2018 to identify English written original and review articles relevant to this topic. Prospective and retrospective studies were included.Evidence synthesis: There are several risk factors identified from non-randomised trials that can be improved before surgery to reduce perioperative mortality and morbidity. These include poor nutritional status, anaemia, renal function and smoking. Preoperative nomograms have also been developed to help decision-making and to inform patients about the risks of surgery. They can be used to estimate risk of postoperative mortality af...Continue Reading

References

Feb 11, 2003·The Journal of Urology·Harry W Herr
Mar 12, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M M KnapJ Overgaard
Aug 29, 2003·The New England Journal of Medicine·H Barton GrossmanE David Crawford
May 1, 1956·Cancer·G R PROUT, V F MARSHALL
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Achim FleischmannUrs E Studer
Jun 11, 2005·The Journal of Urology·Marcus L QuekDonald G Skinner
Aug 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yair LotanArthur I Sagalowsky
Jul 13, 2006·European Urology·Pierre I KarakiewiczSeth P Lerner
Jul 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN International Bladder Cancer Nomogram ConsortiumKinjal C Vora
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shahrokh F ShariatSeth P Lerner
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wassim KassoufAshish M Kamat
May 19, 2009·The Journal of Urology·Hendrik IsbarnPierre I Karakiewicz
Jun 2, 2009·European Urology·Michael FroehnerUrs E Studer
Jul 28, 2009·Journal of Clinical Epidemiology·David MoherUNKNOWN PRISMA Group
Nov 16, 2010·The Journal of Urology·Justin R GreggDaniel A Barocas
Sep 22, 2012·European Urology·Richard E HautmannUNKNOWN International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012
Jan 7, 2014·European Urology·Atiqullah AzizUNKNOWN PROMETRICS 2011 research group
Jan 16, 2014·The Journal of Urology·Angela B SmithMatthew E Nielsen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

International Journal of Clinical Oncology
Hiroshi KitamuraTaiji Tsukamoto
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Alessandro LarcherPierre I Karakiewicz
© 2022 Meta ULC. All rights reserved